123 results on '"McLaughlin, Peter"'
Search Results
2. Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial
3. Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
4. Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial
5. The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP
6. Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial
7. Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma
8. Management Options for Follicular Lymphoma: Observe; R-CHOP; B-R; Others?
9. The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Follicular Lymphoma: An Evidence-Based Review
10. Transcatheter closure of atrial septal defects with multiple devices in adults: Procedural and clinical outcomes
11. Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
12. Predictors of Atrial Arrhythmias After Device Closure of Secundum Type Atrial Septal Defects in Adults
13. Reverend Paley’s naturalist revival
14. The Role of Cardiac Catheterization in Adult Congenital Heart Disease
15. Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha
16. A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I–III follicular lymphoma
17. Follicular Lymphoma International Prognostic Index
18. Chapter 10 Geology and hydrogeology of St. Croix, Virgin Islands
19. N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up
20. Update on the Activity of Rituximab/CHOP Combinations in Non-Hodgkin's Lymphoma
21. Central lymphatic irradiation for stage I–III follicular lymphoma: report from a single-institutional prospective study
22. Stage III follicular lymphoma: long-term follow-up and patterns of failure
23. A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancer
24. Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone
25. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
26. Right ventricular form and function after percutaneous atrial septal defect device closure
27. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21)
28. Long-term results with radiotherapy for stage I–II follicular lymphomas
29. Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression
30. Fine Motor Control in Rats is Disrupted by Delta-9-Tetrahydrocannabinol
31. Correlation of Bcl-2 Rearrangement With Clinical Characteristics and Outcome in Indolent Follicular Lymphoma
32. Hodgkin’s disease with lymphocyte predominance: long-term results based on current histopathologic criteria
33. Chapter 13 Evolution of the neogene kingshill basin of St. Croix, U.S. Virgin Islands
34. Determinants of survival and length of survival in adults with Eisenmenger syndrome
35. A broken heart: Right-to-left shunt in the setting of normal cardiac pressures
36. CD4 + CD56 + hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate
37. Atrial septal defect closure in a patient with “irreversible” pulmonary hypertensive arteriopathy
38. A Single Center Phase II Trial Of 90yttrium-Ibritumomab-Tiuxetan Produces High Response Rates As First-Line Therapy For Early Stage B Cell Indolent Lymphoma, Including Bulky Disease
39. Long Term Results Of a Phase 2 Study Of Vincristine Sulfate Liposome Injection (Marqibo®) Substituted For Non-Liposomal Vincristine In CHOP With Or Without Rituximab For Patients With Untreated Aggressive Non-Hodgkin's Lymphomas
40. A Tribute to Dr Lillian M. Fuller
41. Lenalidomide and Rituximab for Untreated Indolent Lymphoma: Final Results of a Phase II Study
42. Phase II Study with R-FND Followed by 90-Y Ibritumomab Tiuxetan Radioimmunotherapy and Rituximab Maintenance for Untreated High-Risk Follicular Lymphoma
43. Bone Loss in Lymphoma Patients Prior to Receiving Front-line Therapy
44. Randomized Clinical Trial of Rasburicase Administered as a Standard Fixed Five Days Dosing Vs a Single Dose Followed by as Needed Dosing in Adult Patients with Hematologic Malignancies at Risk for Developing Tumor Lysis Syndrome.
45. Bone Loss in Lymphoma Patients Receiving Frontline Therapy: Urine NTx and Bone Specific Alkaline Phosphatase Provide Early Evidence of Zoledronic Acid Response.
46. Bone Loss in Patients with Previously Untreated Lymphoma: The Effect of Periodontal Disease on the Use of Zoledronic Acid
47. Marginal Zone Lymphoma: Factors That Affect the Final Outcome, a Study of 275 Patients
48. Incidence of Transformation to Large Cell Lymphoma and to Second Malignancies in Symptomatic Patients with Waldenstrom's Macroglobulinemia (WM) Treated with Cladribine (2-CdA) Combination Induction Therapy
49. R-FND Followed by Radioimmunotherapy for High-Risk Follicular Lymphoma
50. Phase I Trial of Bortezomib in Combination with Rituximab-HyperCVAD/Methotrexate and Cytarabine for Untreated Mantle Cell Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.